Hester Biosciences Limited — Board Meeting, 30-07-2026: Outcome of Board Meeting
30-07-2026 | 11:18 am
30-07-2026 | 11:18 am
Hester Biosciences' board approved Q1 financial results. Consolidated revenue dipped 8% to ₹77.24 Cr, but profit surged 459% to ₹96.73 Cr. This profit boost largely stems from an ₹85.35 Cr exceptional gain due to a revised Gates Foundation loan at Hester Africa.
No comments yet. Be the first to comment!
